Key facts
- This page summarizes Rita M. O'Connor's Form 4 filing for PLx Pharma Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Mar 2022, 08:33.
Rita M. O'Connor - 15 Mar 2022 Form 4 Insider Report for PLx Pharma Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 15 Mar 2022
- Net transaction value
- +$50,122
- SEC form
- 4
- Accepted by SEC
- 16 Mar 2022, 08:33:47 UTC
- Prior SEC filing
- 24 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rita M. O'Connor
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Rita M. O'Connor filed Form 4 for PLx Pharma Inc. on 16 Mar 2022.
Change
- Previous filing in this sequence was filed on 24 Feb 2022.
- Current net transaction value: +$50,122.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PLXPQ
transaction
Common Stock
Purchase
- Transaction value
- $36,600
- Shares
- +10,000
- Change %
- +77%
- Price
- $3.66
- Shares after
- 22,970
- Date
- 15 Mar 2022
- Ownership
- Direct
PLXPQ
transaction
Common Stock
Purchase
- Transaction value
- $13,522
- Shares
- +3,700
- Change %
- +16%
- Price
- $3.65
- Shares after
- 26,670
- Date
- 15 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.